Cetera Advisor Networks’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-244
Closed -$5K 1519
2020
Q2
$5K Buy
+244
New +$4.37K ﹤0.01% 2963
2016
Q2
Sell
-2,266
Closed -$255K 838
2016
Q1
$255K Hold
2,266
0.02% 662
2015
Q4
$246K Buy
2,266
+2
+0.1% +$229 0.02% 677
2015
Q3
$224K Sell
2,264
-30
-1% -$3.26K 0.02% 683
2015
Q2
$238K Hold
2,294
0.02% 705
2015
Q1
$238K Buy
2,294
+301
+15% +$32.1K 0.02% 709
2014
Q4
$241K Sell
1,993
-10
-0.5% -$1.31K 0.02% 695
2014
Q3
$293K Sell
2,003
-180
-8% -$27.8K 0.02% 615
2014
Q2
$365K Buy
2,183
+600
+38% +$107K 0.02% 557
2014
Q1
$315K Buy
1,583
+55
+4% +$10.4K 0.02% 571
2013
Q4
$295K Buy
1,528
+268
+21% +$49.9K 0.02% 562
2013
Q3
$213K Buy
+1,260
New +$196K 0.02% 605

Other funds holding CLB

Cetera Advisor Networks's CLB Position: Q3 2020 in Review

Cetera Advisor Networks sold out of Core Laboratories (CLB) in Q3 2020, closing a stake of 244 shares — an estimated $5K sold.

Cetera Advisor Networks first reported a position in CLB in Q3 2013 and held it in 12 quarters. The position peaked at $365K in Q2 2014. 187 funds tracked by Wall St. Rank hold CLB as of Q3 2020.

  • Cetera Advisor Networks reported no remaining Core Laboratories position as of Q3 2020 after selling out during the quarter.
  • Cetera Advisor Networks sold 244 Core Laboratories shares in Q3 2020, an estimated $5K.
  • Cetera Advisor Networks first reported a position in Core Laboratories in Q3 2013 and held it in 12 quarters.
  • Cetera Advisor Networks's Core Laboratories position peaked at $365K in Q2 2014.
  • 187 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2020.

Based on Cetera Advisor Networks's 13F filing for Q3 2020, filed 13 Nov 2020.